Zentek (TSE:ZEN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zentek’s subsidiary, Triera Biosciences, has secured a $1.1 million contract from the Government of Canada to test its innovative multivalent aptamer technology. This funding will support the development of rapid drug discovery solutions for highly pathogenic avian influenza, showcasing the government’s commitment to advancing the life sciences sector in Canada.
For further insights into TSE:ZEN stock, check out TipRanks’ Stock Analysis page.